Skip to main content
. 2022 Jun 13;21:15347354221105498. doi: 10.1177/15347354221105498

Figure 3.

Figure 3.

Site of cancer progression in metastatic colorectal cancer patients treated with bevacizumab, FOLFIRI, and ginsenoside-modified nanostructured lipid carrier containing curcumin.